|Mr. Bryan C. Hanson||Pres, CEO & Director||2.61M||N/A||1967|
|Mr. Chad F. Phipps||Sr. VP, Gen. Counsel & Sec.||910.94k||3.78M||1972|
|Mr. Sang Yi||Pres of Asia Pacific||1.06M||N/A||1962|
|Mr. Ivan Tornos||Group Pres of Orthopedics||998.77k||N/A||1976|
|Mr. Suketu P. Upadhyay||Exec. VP & CFO||N/A||N/A||1969|
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and office based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Zimmer Biomet Holdings, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 9. The pillar scores are Audit: 3; Board: 6; Shareholder Rights: 6; Compensation: 10.